National & International Grants

National & International Grants

Nationally Funded Projects

ZF GGAA landscape
CCRI responsible principal investigator: Niko Popitsch
Grant from the Austrian Research Promotion Agency (FFG), Call Talente FEMTech Praktika Studentinnen 2018
Duration: 01/08/2018 to 30/09/2018

Phylogenetic analysis of primary and disseminated tumor cells to reconstruct the metastatic route of relapsed neuroblastomas
CCRI responsible principal investigator: Reza Abbasi
Grant from the Ingrid Shaker Nessmann Krebsforschungsvereinigung (ISNK) – Forschungsförderung 2018
Duration: 01/02/2018 to 31/01/2019

Analysis of temporal and spatial Ewing sarcoma tumor evolution during chemotherapy and validation of its clinical implication
CCRI coordinator: Eleni Tomazou
Grant from the Austrian National Bank (OeNB), Jubiläumsfonds
Duration: 01/09/2018 to 31/08/2021

Platform supporting an integrated analysis of image and multiOMICs data based on liquid biopsies for tumor diagnostics (VISIOMICS)
Labdia Coordinator: Sabine Taschner-Mandl, Peter Ambros
Grant from the Austrian Research Promotion Agency (FFG), COIN Programme
Duration: 01/11/2017 to 31/10/2019

Establishing a zebrafish disease model drug screening platform, (Danio4Can)
CCRI responsible principal investigator: Martin Distel
Grant from the Austrian Research Promotion Agency (FFG), R&D Infrastrukturförderung, 1st Call
Duration: 01/05/2017 to 30/04/2019

Role of stress granules in Ewing sarcoma susceptibility
CCRI responsible principal investigator: Heinrich Kovar
Grant from the Austrian Science Fund (FWF), Stand Alone Project
Duration: 01/06/2017 to 31/05/2020

Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe (ONTHETRRAC)
CCRI responsible principal investigator: Peter Ambros
Grant from the Austrian Science Fund (FWF), ERA-Net Transcan
Duration: 01/01/2016 to 30/09/2018

Ewing sarcoma – an enhancer disease?
CCRI responsible principal investigator: Eleni Tomazou
Grant from the Austrian Science Fund (FWF), Elise Richter Programme
Duration: 01/01/2016 to 31/12/2019

TRANSCALL (Translational research in childhood acute lymphoblastic leukemia)
CCRI responsible principal investigator: Renate Panzer-Grümayer
Grant from the Austrian Science Fund (FWF), ERA-Net Transcan
Duration: 01/07/2013 to 30/06/2017

PROVABES (prospective validation of biomarkers in Ewing sarcoma for personalized treatment)
CCRI responsible principal investigator: Heinrich Kovar
Grant from the Austrian Science Fund (FWF), ERA-Net Transcan
Duration: 01/04/2013 to 31/03/2017

Myeloproliferative neoplasms
CCRI partner: Thomas Lion Coordinator: Peter Valent (Medical University of Vienna, Austria)
Grant from the Austrian Science Fund (FWF), Special Research Programme (SFB)
Duration: 01/03/2013 to 28/02/2017

Verfahren zur hochautomatisierten Bewertung und Klassifikation von Zellen in Gewebeschnitten anhand räumlicher Markerprofile (TisQuant)
LABDIA responsible principal investigator: Peter Ambros
Grant from the Austrian Research Promotion Agency (FFG), ERA-SME
Duration: 01/06/2014 to 31/05/2017

Directed in vitro differentiation of induced pluripotent stem cells towards the B lymphoid lineage (B-different)
CCRI coordinator: Klaus Fortschegger
Grant from the Austrian Research Promotion Agency (FFG), Call Bridge (Brückenschlagprogramm)
Duration: 01/06/2014 to 22/12/2017

Virus-specific immunotherapy (VISIT)
CCRI/Labdia: coordinator René Geyeregger (Labdia), partner: Matthes-Leodolter (CCRI)
Grant from the Wirtschaftsagentur Wien, Call Life Sciences 2014
Duration: 01/04/2015 to 31/03/2018

Automated MRD-assessment in AML (flowCLUSTER)
Labdia coordinator: Michael Dworzak
Grant from the Wirtschaftsagentur Wien, Call Life Sciences 2014
Duration: 01/03/2015 to 28/02/2018

Liquid biopsy in neuroblastoma: chance for diagnosis, prognosis and disease monitoring
CCRI responsible principal investigator: Peter Ambros
Grant from the Austrian National Bank (OeNB), Jubiläumsfonds
Duration: 01/01/2016 to 30/09/2018

Permanent consequences in childhood Langerhans cell histiocytosis
CCRI responsible principal investigator: Milen Minkov
Grant from the Austrian National Bank (OeNB), Jubiläumsfonds
Duration: 01/09/2015 to 31/12/2018

Verbesserte Patientenkommunikation in der Onkologie mittels INTERACCT App (OCCURSUS)
CCRI responsible principal investigator: Anita Lawitschka
Grant from the „Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie“
Duration: 01/05/2016 to 31/07/2017

Internationally Funded Projects

PRedictive In-silico Multiscale Analytics (PRIMAGE)
CCRI responsible principal investigator: Ruth Ladenstein
European Commission Grant – Call H2020-SC1-DTH-2018-2020
Duration: 01/12/2018 to 30/11/2022

Integrated European Network on cGvHD
CCRI responsible principal investigator: Anita Lawitschka
European Commission Grant – COST Action
Duration: 31/08/2018 to 30/08/2022

ERN-PAEDCAN-CEF-Telecom
CCRI Coordinator: Ruth Ladenstein
European Commission Grant – Call CEF-TC-2017-2
Duration: 01/05/2018 to 31/08/2019

ERN-PAEDCAN Partner: Paediatric Rare Tumours Network - European Registry (PARTNER)
CCRI responsible principal investigator: Ruth Ladenstein
European Commission Grant – Call CEF-TC-2017-2
Duration: 01/01/2018 to 31/12/2020

Paediatric Cancer European Reference Network (ERN PaedCan)
CCRI Coordinator: Ruth Ladenstein
Grant from the European Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
Duration: 01/03/2017 to 28/02/2022

ITCC Pediatric Preclinical POC Platform (ITCCP4)
CCRI partner: Heinrich Kovar Coordinator: Stefan Pfister (Deutsches Krebsforschungszentrum DKFZ, Germany)
European Commission Grant – H2020 Innovative Medicines Initiative
Duration: 01/01/2017 to 31/12/2021

Optimized diagnostics for improved treatment stratification in invasive fungal diseases (FUNGITECT)
CCRI/Labdia Coordinator: Thomas Lion
European Commission Grant – FP7 Cooperation Project
Duration: 01/02/2014 to 31/01/2019

Automation of flow cytometric analysis for quality-assured follow-up assessment to guide curative therapy for acute lymphoblastic leukaemia in children (AutoFLOW)
CCRI/Labdia partner: Michael Dworzak Coordinator: Martin Kampel (Technical University of Vienna, Austria)
European Commission Grant – FP7 Industry-Academia Partnerships and Pathways (Marie Curie Actions)
Duration: 01/02/2014 to 31/12/2017

EURO EWING Consortium – International clinical trials to improve survival from Ewing sarcoma (EEC)
CCRI partner: Heinrich Kovar Coordinator: Jeremy Whelan (University College London, UK)
European Commission Grant – FP7 Cooperation Project
Duration: 01/10/2013 to 31/12/2018

Molecular mechanisms of human fungal pathogen host interaction (ImResFun)
CCRI partner: Thomas Lion Coordinator: Karl Kuchler (Medical University of Vienna, Austria)
European Commission Grant – FP7 Initial Training Network (Marie Curie Actions)
Duration: 01/10/2013 to 30/08/2017

Expert paediatric oncology reference network for diagnostics and treatment (ExPO-r-Net)
CCRI Coordinator: Ruth Ladenstein
Grant from the European Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
Duration: 01/03/2014 to 31/08/2017

International study for treatment of childhood relapsed ALL 2010 (IntReALL)
CCRI partners: Georg Mann, Andishe Attarbaschi and Ruth Ladenstein Coordinator: Jeremy Whelan (University College London, UK)
European Commission Grant – FP7 Cooperation Project
Duration: 01/10/2011 to 30/09/2017

PanCare childhood and adolescent cancer survivor care and follow-up studies (PanCareSurFup)
CCRI/St Anna Spital partners: Eva Frey Coordinator: Lars Hjorth (Lund University, Sweden) European Commission Grant – FP7 Cooperation Project
Duration: 01/02/2011 to 10/02/2017